242 related articles for article (PubMed ID: 18310294)
1. Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor.
Redondo-Müller MA; Stevanovic-Walker M; Barker S; Puddefoot JR; Vinson GP
Endocr Relat Cancer; 2008 Mar; 15(1):277-88. PubMed ID: 18310294
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL
Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C-mediated inhibition of renal Ca2+ ATPase by physiological concentrations of angiotensin II is reversed by AT1- and AT2-receptor antagonists.
Assunção-Miranda I; Guilherme AL; Reis-Silva C; Costa-Sarmento G; Oliveira MM; Vieyra A
Regul Pept; 2005 Apr; 127(1-3):151-7. PubMed ID: 15680481
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
Zhao Y; Peng J; Zheng L; Yu W; Jin J
Prostate; 2010 Jun; 70(8):899-905. PubMed ID: 20135646
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin receptors in hormone-independent prostate cancer cell line DU145: presence of two variants of angiotensin type 1 receptor.
Sidorkiewicz M; Rebas E; Szymajda M; Ławnicka H; Pawlikowski M; Lachowicz A
Med Sci Monit; 2009 Apr; 15(4):BR106-10. PubMed ID: 19333191
[TBL] [Abstract][Full Text] [Related]
6. Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma.
De Paepe B; Verstraeten VL; De Potter CR; Vakaet LA; Bullock GR
Histochem Cell Biol; 2001 Sep; 116(3):247-54. PubMed ID: 11685554
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
[TBL] [Abstract][Full Text] [Related]
8. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide-containing nerves in rat mesenteric arteries.
Hobara N; Goda M; Yoshida N; Takatori S; Kitamura Y; Mio M; Kawasaki H
Neuroscience; 2007 Dec; 150(3):730-41. PubMed ID: 17950540
[TBL] [Abstract][Full Text] [Related]
10. Effects of losartan on angiotensin receptors in the hypertrophic rat heart.
Sim MK; Chen WS
Regul Pept; 2006 Dec; 137(3):140-6. PubMed ID: 16928404
[TBL] [Abstract][Full Text] [Related]
11. Translocation of AT1- and AT2-receptors by higher concentrations of angiotensin II in the smooth muscle cells of rat internal anal sphincter.
de Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Dec; 319(3):1088-95. PubMed ID: 16985169
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
Banks T; Oyekan A
J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles.
Baranov D; Armstead WM
Eur J Pharmacol; 2005 Nov; 525(1-3):112-6. PubMed ID: 16256981
[TBL] [Abstract][Full Text] [Related]
14. Evidence of an intracellular angiotensin-generating system and non-AT1, non-AT2 binding site in a human pancreatic cell line.
Pérez-Díaz I; Guzmán C; Olivares-Reyes JA; Ramírez T; Gutierréz-Reyes G; Hiriart M; Robles-Díaz G
Pancreas; 2011 Jul; 40(5):701-7. PubMed ID: 21602736
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
Dragun D; Müller DN; Bräsen JH; Fritsche L; Nieminen-Kelhä M; Dechend R; Kintscher U; Rudolph B; Hoebeke J; Eckert D; Mazak I; Plehm R; Schönemann C; Unger T; Budde K; Neumayer HH; Luft FC; Wallukat G
N Engl J Med; 2005 Feb; 352(6):558-69. PubMed ID: 15703421
[TBL] [Abstract][Full Text] [Related]
16. The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis.
Tsang SW; Cheng CH; Leung PS
Regul Pept; 2004 Jul; 119(3):213-9. PubMed ID: 15120483
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation.
Shibata E; Powers RW; Rajakumar A; von Versen-Höynck F; Gallaher MJ; Lykins DL; Roberts JM; Hubel CA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1009-16. PubMed ID: 16787961
[TBL] [Abstract][Full Text] [Related]
18. Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells.
Weidekamm C; Hauser P; Hansmann C; Schwarz C; Klingler H; Mayer G; Oberbauer R
Wien Klin Wochenschr; 2002 Aug; 114(15-16):725-9. PubMed ID: 12602118
[TBL] [Abstract][Full Text] [Related]
19. Changes in angiotensin II type 1 receptor signalling pathways evoked by a monoclonal antibody raised to the N-terminus.
Xiao F; Puddefoot JR; Barker S; Vinson GP
J Endocrinol; 2008 Apr; 197(1):25-33. PubMed ID: 18372229
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
